FAQ
Everything you wanted to ask.
Getting started
Weight loss & GLP-1s
Mental health
Billing & cancellation
Ready to feel like yourself again?
Start a confidential visit in minutes. Pay only if prescribed.
Scientific References
Peer-reviewed studies (2021 and newer) referenced on this page.
- Aronne LJ, et al. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity. N Engl J Med. 2025.
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205–216.
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021;384(11):989–1002.
- Bahji A, et al. Efficacy and safety of ketamine and esketamine for unipolar and bipolar depression: an overview of systematic reviews with meta-analysis. 2024.
- Long-Term Outcomes in Patients With Treatment-Refractory Depression Receiving Intravenous Ketamine and Intranasal Esketamine. 2025.
- Safety and tolerability of esketamine nasal spray versus quetiapine extended release in patients with treatment-resistant depression. 2024.
- Johnson et al. Effectiveness of Combined Oral Minoxidil and Finasteride in Men with Androgenetic Alopecia. 2025.
- Abeck D, et al. Patient-reported outcomes of topical finasteride/minoxidil treatment for male androgenetic alopecia. J Cosmet Dermatol. 2024.
- Piraccini BM, et al. Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia. J Cosmet Dermatol. 2022.
- Pyrgidis N, et al. Assessment of Combination Therapies vs Monotherapy for Erectile Dysfunction: A Systematic Review and Meta-analysis. JAMA Network Open. 2021;4(2):e2036337.
- Huang Y, et al. Effect of phosphodiesterase-type 5 inhibitors on erectile function: an overview of systematic reviews and meta-analyses. BMJ Open. 2021;11(8):e047396.
- Associations between phosphodiesterase type 5 inhibitors and vascular function: a systematic review and meta-analysis of randomized controlled trials. Systematic Reviews. 2025.